Cargando…
Randomized controlled expressive writing pilot in individuals with Parkinson’s disease and their caregivers
BACKGROUND: Individuals with Parkinson’s disease (PD) and their caregivers are at risk for emotional distress and hypercortisolism. Expressive writing is an effective complementary intervention to ameliorate the psychological and physiological effects of chronic illness. This pilot study aimed to ev...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4666161/ https://www.ncbi.nlm.nih.gov/pubmed/26621025 http://dx.doi.org/10.1186/s40359-015-0101-4 |
_version_ | 1782403671469850624 |
---|---|
author | Cash, Therese Verkerke Lageman, Sarah K. |
author_facet | Cash, Therese Verkerke Lageman, Sarah K. |
author_sort | Cash, Therese Verkerke |
collection | PubMed |
description | BACKGROUND: Individuals with Parkinson’s disease (PD) and their caregivers are at risk for emotional distress and hypercortisolism. Expressive writing is an effective complementary intervention to ameliorate the psychological and physiological effects of chronic illness. This pilot study aimed to evaluate feasibility and preliminary effectiveness of an expressive writing intervention for individuals with PD and their caregivers. METHODS: Individuals with PD (N = 27) and their caregivers (N = 14) were randomly assigned to expressive (N = 15 patients, eight caregivers) or neutral (N = 12 patients, six caregivers) writing conditions. Cortisol awakening response (CAR), non-motor functioning, quality of life, and performance on tests of cognitive functioning were assessed at baseline, immediate post, 4-month, and 10-month post intervention. RESULTS: Attrition was a challenge as eight patients (29.62 %) and four caregivers (28.57 %) chose to discontinue before beginning the intervention or were lost to follow up prior to completing the intervention or the first follow up visit. Significant reduction in anxiety, marginally significant improvement in depression and caregiver burden, and significant improvements in performance on tests of learning and memory were observed, but these changes did not differ by writing condition. CAR significantly differed over time between patients and caregivers and writing conditions. CONCLUSIONS: Some evidence for the feasibility and effectiveness of writing to alleviate hypercortisolism was demonstrated in a small sample of PD patients; however, relatively high attrition rates and the lack of difference between expressive and neutral writing conditions on emotional and neurocognitive outcomes suggests expressive writing procedure modifications may be needed to obtain optimal results for this population. TRIAL REGISTRATION: ClinicalTrials.gov, NCT02217735, Study Start Date: August 30, 2011. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40359-015-0101-4) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4666161 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46661612015-12-02 Randomized controlled expressive writing pilot in individuals with Parkinson’s disease and their caregivers Cash, Therese Verkerke Lageman, Sarah K. BMC Psychol Research Article BACKGROUND: Individuals with Parkinson’s disease (PD) and their caregivers are at risk for emotional distress and hypercortisolism. Expressive writing is an effective complementary intervention to ameliorate the psychological and physiological effects of chronic illness. This pilot study aimed to evaluate feasibility and preliminary effectiveness of an expressive writing intervention for individuals with PD and their caregivers. METHODS: Individuals with PD (N = 27) and their caregivers (N = 14) were randomly assigned to expressive (N = 15 patients, eight caregivers) or neutral (N = 12 patients, six caregivers) writing conditions. Cortisol awakening response (CAR), non-motor functioning, quality of life, and performance on tests of cognitive functioning were assessed at baseline, immediate post, 4-month, and 10-month post intervention. RESULTS: Attrition was a challenge as eight patients (29.62 %) and four caregivers (28.57 %) chose to discontinue before beginning the intervention or were lost to follow up prior to completing the intervention or the first follow up visit. Significant reduction in anxiety, marginally significant improvement in depression and caregiver burden, and significant improvements in performance on tests of learning and memory were observed, but these changes did not differ by writing condition. CAR significantly differed over time between patients and caregivers and writing conditions. CONCLUSIONS: Some evidence for the feasibility and effectiveness of writing to alleviate hypercortisolism was demonstrated in a small sample of PD patients; however, relatively high attrition rates and the lack of difference between expressive and neutral writing conditions on emotional and neurocognitive outcomes suggests expressive writing procedure modifications may be needed to obtain optimal results for this population. TRIAL REGISTRATION: ClinicalTrials.gov, NCT02217735, Study Start Date: August 30, 2011. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40359-015-0101-4) contains supplementary material, which is available to authorized users. BioMed Central 2015-11-30 /pmc/articles/PMC4666161/ /pubmed/26621025 http://dx.doi.org/10.1186/s40359-015-0101-4 Text en © Cash and Lageman. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Cash, Therese Verkerke Lageman, Sarah K. Randomized controlled expressive writing pilot in individuals with Parkinson’s disease and their caregivers |
title | Randomized controlled expressive writing pilot in individuals with Parkinson’s disease and their caregivers |
title_full | Randomized controlled expressive writing pilot in individuals with Parkinson’s disease and their caregivers |
title_fullStr | Randomized controlled expressive writing pilot in individuals with Parkinson’s disease and their caregivers |
title_full_unstemmed | Randomized controlled expressive writing pilot in individuals with Parkinson’s disease and their caregivers |
title_short | Randomized controlled expressive writing pilot in individuals with Parkinson’s disease and their caregivers |
title_sort | randomized controlled expressive writing pilot in individuals with parkinson’s disease and their caregivers |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4666161/ https://www.ncbi.nlm.nih.gov/pubmed/26621025 http://dx.doi.org/10.1186/s40359-015-0101-4 |
work_keys_str_mv | AT cashthereseverkerke randomizedcontrolledexpressivewritingpilotinindividualswithparkinsonsdiseaseandtheircaregivers AT lagemansarahk randomizedcontrolledexpressivewritingpilotinindividualswithparkinsonsdiseaseandtheircaregivers |